LATE BREAKING CLINICAL TRIALS | ENDOVASCULAR

Tuesday, March 11, 2025

8:00 AM – 9:00 AM ET

Moderator(s)

Navneet Sharma, MD

Assistant Professor
Cleveland Clinic Foundation

Disclosure(s): No financial relationships to disclose
Andrew SP Sharp, MD

Professor of Cardiology
University College Dublin
Dublin, Ireland

Disclosure(s): AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific, Medtronic, Recor Medical, Philips, Penumbra: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Panelist(s)

Shadi Halabi, MD

Interventional Cardiologist
Powers Healthcare System

Disclosure(s): No financial relationships to disclose
Rohan J. Kalathiya, MD

Interventional Cardiologist - Assistant Professor of Medicine, Division of Cardiology
Johns Hopkins School of Medicine
Potomac, Maryland, United States

Disclosure(s): No financial relationships to disclose
Giorgio A. Medranda, MD

Structural Interventional Cardiologist
NYU Langone Hospital - Long Island
Glen Cove, New York, United States

Disclosure(s): No financial relationships to disclose
M. Reza Movahed, Prof.

Clinical Professor of Medicine
University of Arizona, Tucson and Phoenix
Tucson, Arizona, United States

Disclosure(s): No financial relationships to disclose
Rachel Rosovsky, MD, MPH

Associate Professor, Harvard Medical school
Massachusetts General Hospital
Boston, Massachusetts, United States

Disclosure(s): Boston Scientific Corporation: Consultant (Ongoing); Inquis Medical: Consultant (Ongoing); Janssen Pharmaceuticals: Consultant (Ongoing); Penumbra, Inc.: Consultant (Ongoing), Global PI for International device trial; research funds go to my institution (Ongoing), Grant/Research Support (Ongoing)
On Topaz, FACC, FSCAI,FACP

Professor of Medicine ,Duke University School of Medicine.
Duke University School of Medicine/Charles George VAMC Charles George Veterans Affairs MC Charles George Veterans Affairs MC
Biltmore Lake, North Carolina, United States

Disclosure(s): Angiodynamics/Auryon: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Andrew SP Sharp, MD: AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific, Medtronic, Recor Medical, Philips, Penumbra: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Giorgio A. Medranda, MD: No financial relationships to disclose

Rachel Rosovsky, MD, MPH: Boston Scientific Corporation: Consultant (Ongoing); Inquis Medical: Consultant (Ongoing); Janssen Pharmaceuticals: Consultant (Ongoing); Penumbra, Inc.: Consultant (Ongoing), Global PI for International device trial; research funds go to my institution (Ongoing), Grant/Research Support (Ongoing)

Kenneth Rosenfield, MD, MHCDS: Abbott Vasular: Consulting Fees (e.g., advisory boards) (Ongoing); Akura: Stock-privately held company (Ongoing); Angiodynamics: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Grant/Research Support (Ongoing); Contego: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Fastwave: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Imperative Care: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Innova Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Inspire MD: Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); MiRus: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); NAMSA: Consulting Fees (e.g., advisory boards) (Ongoing); Neptune: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing); Radiaction: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Sonovascular: Stock-privately held company (Ongoing); Thrombolex: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vantis Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vasorum: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Viz.ai: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); VuMedi: Stock-privately held company (Ongoing)

On Topaz, FACC, FSCAI,FACP: Angiodynamics/Auryon: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)